Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000136

Chief Medical Officer sold 2,522 shares at $23.22 ($58,561)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-23 Sale : show line 1 in the form −2,522 $23.22 $58,561 182,809 I
Open-market sales · 2,522 sh · avg $23.22 · $58,561
Loading xslF345X05/wk-form4_1692999010.xml…